CLDX
CLDX
US15117B2025
Celldex Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.35B EUR
2.92B EUR
2.11B EUR
1.81B EUR
Enterprise Value
1.59B EUR
2.88B EUR
2.08B EUR
1.78B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.06x
--
--
--
Price to Sales
14,856x
18,487.25x
2,438.3x
2,123.95x
Price to Book
3.28x
4.09x
4.63x
3.43x
EV/Revenue
10,052.1x
18,217.94x
2,399.25x
2,092.77x
EV/EBITDA
-4.93x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-5.67%
-8.29%
-10.71%
-8.8%
ende